Fig. 4.

Performance of Leishmania Antigen Detect™ ELISA and Leishmania Antigen ELISA on treatment follow- up urine samples from Ethiopia. a. Mean ELISA signals of 42 VL patients undergoing SSG, MEG or L-AmB treatment in Ethiopia at initiation (Day 0) and post initiation (Days 30 and 180) of treatment as measured by the Leishmania Antigen Detect™ ELISA. Dotted line indicates cut-off value for positivity as calculated from the mean of negative controls added 3 standard deviations. b. UAU/mL for 42 VL patients undergoing SSG, MEG or L-AmB treatment in Ethiopia at initiation (Day 0) and post initiation (Days 30 and 180) of treatment as measured by the Leishmania Antigen ELISA c. Positivity percentage of the Leishmania Antigen Detect™ ELISA (Black bars) and Leishmania Antigen ELISA (dark gray bars) compared to KAtex (light gray bars) on VL patient urine samples from Ethiopia at initiation (Day 0) and post initiation (Days 30 and 180) of treatment